Karyopharm Therapeutics Inc
SWB:25K
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
K
|
Karyopharm Therapeutics Inc
SWB:25K
|
US |
|
Italian Wine Brands S.P.A.
MIL:IWB
|
IT |
|
JCDecaux SE
F:DCS0
|
FR |
|
McDonald's Holdings Company Japan Ltd
OTC:MDNDF
|
JP |
|
Fox Corp
LSE:0A0X
|
US |
|
Orege SA
F:4ZF
|
FR |
|
Copart Inc
NASDAQ:CPRT
|
US |
|
Marimaca Copper Corp
ASX:MC2
|
CA |
|
N
|
Nampak Ltd
XBER:NNZA
|
ZA |
|
S
|
State Bank of India
F:SID
|
IN |
|
U
|
US Bancorp
BMV:USB
|
US |
|
K
|
KGL Resources Ltd
XMUN:KN6
|
AU |
|
V
|
Veolia Environnement SA
XHAM:VVD
|
FR |
|
S
|
Stockmann Oyj Abp
F:SOMB
|
FI |
|
CF Industries Holdings Inc
NYSE:CF
|
US |
|
Nel ASA
OTC:NLLSY
|
NO |
Bankruptcy Probability
Karyopharm Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Karyopharm Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Karyopharm Therapeutics Inc
NASDAQ:KPTI
|
205.1m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
384.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
181.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
167B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
113.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
65B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
44.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
40.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Karyopharm Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Karyopharm Therapeutics Inc has total debt of 278.2m USD. This includes both short-term (0 USD) and long-term (278.2m USD) debt.
You can find a full breakdown on its Balance Sheet.
